IBT
IFRX icon

International Biotechnology Trust’s InflaRx IFRX Stock Holding History

International Biotechnology Trust’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-220,000
Closed -$869K – 58
2019
Q4 		$869K Buy
+220,000
New +$643K 0.31% 51
2019
Q2 		– Sell
-32,500
Closed -$1.22M – 66
2019
Q1 		$1.22M Buy
+32,500
New +$1.21M 0.45% 51

Other funds holding IFRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

International Biotechnology Trust's IFRX Position: Q1 2020 in Review

International Biotechnology Trust sold out of InflaRx (IFRX) in Q1 2020, closing a stake of 220,000 shares — an estimated $869K sold.

International Biotechnology Trust first reported a position in IFRX in Q1 2019 and held it in 2 quarters. The position peaked at $1.22M in Q1 2019. 26 funds tracked by Wall St. Rank hold IFRX as of Q1 2020.

  • International Biotechnology Trust reported no remaining InflaRx position as of Q1 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 220,000 InflaRx shares in Q1 2020, an estimated $869K.
  • International Biotechnology Trust first reported a position in InflaRx in Q1 2019 and held it in 2 quarters.
  • International Biotechnology Trust's InflaRx position peaked at $1.22M in Q1 2019.
  • 26 funds tracked by Wall St. Rank held InflaRx as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.